GlassScriptPhysician profile
Matthew Lee Bloom
NPI 1801273305
$19,277.73
in general payments reported to CMS, 2019-2025
38 companies · $3,837 in 2025
The $3,837 reported for 2025 was more than what 96% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,812 · 2020: $267 · 2021: $1,726 · 2022: $3,042 · 2023: $4,575 · 2024: $3,018 · 2025: $3,837.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,991 · Travel and Lodging: $1,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,991.33 |
| Travel and Lodging | $1,439.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,551.03 | 2022-2025 | General - Therapies, General - Pain Management, Axios |
| Abbvie INC. | $2,748.05 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Medtronic, INC. | $2,261.16 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Kyphon Express II Kyphopak Tray |
| Arthrex, INC. | $1,948.21 | 2019 | |
| Spr Therapeutics, INC | $1,350.28 | 2023-2025 | Sprint Pns System |
| Allergan, INC. | $1,286.54 | 2019-2022 | |
| Intuitive Surgical, INC. | $515.90 | 2022 | |
| Galderma Laboratories, L.P. | $386.65 | 2021-2025 | Dysport |
| Painteq LLC | $263.68 | 2022-2024 | Painteq |
| Team_makena_llc | $248.27 | 2019-2021 | |
| Nevro Corp. | $226.08 | 2021 | |
| Pfizer INC. | $208.63 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $207.05 | 2022 | |
| Micromed INC | $197.30 | 2019 | |
| Depuy Synthes Sales INC. | $195.30 | 2019-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $182.55 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $180.89 | 2019 | |
| Pacira Therapeutics, INC. | $157.35 | 2019-2021 | |
| Merz North America, INC. | $147.48 | 2022-2025 | Xeomin |
| Biotronik Nro, INC. | $136.47 | 2023 | Biotronik |
| Horizon Therapeutics Plc | $122.13 | 2019-2022 | |
| Abbott Laboratories | $92.70 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $91.58 | 2025 | |
| Bioventus LLC | $81.77 | 2019-2021 | |
| Ibsa Pharma INC. | $81.15 | 2023 | Tirosint, Licart |
| Saluda Medical Americas, INC. | $67.82 | 2024 | Evoke |
| Novo Nordisk INC | $55.36 | 2023-2024 | Wegovy, Saxenda |
| Neurocrine Biosciences, INC. | $37.04 | 2023 | Ingrezza |
| Relievant Medsystems, INC. | $32.64 | 2023 | Intracept |
| Amgen INC. | $30.75 | 2022 | |
| Lilly USA, LLC | $29.53 | 2022 | |
| Indivior INC. | $28.86 | 2024 | Sublocade |
| Grt US Holding, INC. | $28.03 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $23.45 | 2023 | Rexulti |
| Arbor Pharmaceuticals, INC. | $23.05 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $20.41 | 2022 | |
| Endo Pharmaceuticals INC. | $18.66 | 2019 | |
| Mml US, INC. | $13.93 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bloom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.